Patent details

EP1519746 Title: USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS

Basic Information

Publication number:
EP1519746
PCT Application Number:
PCT/US/2003/023235
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037718186
PCT Publication Number:
WO/2004/011028
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS
French Title of Invention:
UTILISATION D'UN FRAGMENT FAB IMMUNE DE DIGOXINE DANS LA REGULATION DE L'ACTIVITE ATPASE SODIUM/POTASSIUM CHEZ DES PATIENTS PREECLAMPTIQUES ET ECLAMPTIQUES
German Title of Invention:
VERWENDUNG VON DIGOXIN-IMMUN-FAB ZUR REGULIERUNG DER NATRIUM/KALIUM-ATPASE-AKTIVITÄT BEI PATIENTEN MIT PRÄEKLAMPSIE UND EKLAMPSIE
SPC Number:

Dates

Filing date:
24/07/2003
Grant date:
15/07/2009
EP Publication Date:
15/07/2009
PCT Publication Date:
05/02/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/04/2005
EP B1 Publication Date:
15/07/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/07/2009
Expiration date:
24/07/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/07/2003
 
 

Name:
Adair Charles David
Address:
22 Mountain Orchard Path, Signal Mountain, TN 37377, United States (US)

Inventor

Name:
Adair Charles David
Address:
United States (US)

Priority

1

Priority Number:
202957
Priority Date:
25/07/2002
Priority Country:
United States (US)

2

Priority Number:
292338
Priority Date:
12/11/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages